Clinical Trial Update: Short-term Additive Effect of Topical Ketorolac on the Management of Diabetic Macular Edema With Intravitreal Bevacizumab [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating the short-term additive effect of topical ketorolac on management of diabetic macular edema with intravitreal bevacizumab has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bevacizumab (bevacizumab)
• ketorolac topical (ketorolac)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: DME | Phase 2, Phase 3 | Status: COMPLETED